Apollo Tyres All Set to Enter the Healthcare Sector
...er-specialty hospital in Gurgaon,// on the outskirts of the national capital, with a seed investment of Rs.2.1 billion ($45 million). Christened artemis Health Sciences (AHS), the 260-bed hospital over 8.3 acres of land will open next month. "In the second phase, another 240 beds will be added," said S...Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
...nalists in the UK or Ireland - New Findings From artemis and TITAN Studies Demonstrate Growth of the ... HIV9. Highlights include: - A new analysis of artemis (AntiRetroviral Therapy with TMC114 Examined In...ith lopinavir/ritonavir in treatment-naive adults. artemis is the first study to examine darunavir/ritonav...Exelixis Announces First Quarter 2008 Financial Results
...ollaboration with Daiichi Sankyo Company Limited for our Mineralocorticoid Receptor (MR) program and the exclusion of revenue of our former subsidiary artemis Pharmaceuticals GmbH, which is no longer consolidated as a result of the sale of 80.1% of our ownership in 2007. These items were offset by the revenu...Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
...tion to include human immunodeficiency virus (HIV)-1-infected, treatment-naive adults. The application includes 48-week data from two Phase 3 studies, artemis and TITAN, which were presented at HIV conferences earlier this year, as well as 96-week data from the Phase 2b studies, POWER 1, 2, and 3. PREZISTA...Exelixis Sells 80% Stake in Artemis to Taconic
SOUTH SAN FRANCISCO, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL ) today announced that it has entered into an agreement with Taconic Farms, Inc. (Hudson, NY) pursuant to which Exelixis sold Taconic an 80.1% stake in its subsidiary Artemis Pharmaceuticals GmbH for a...New Report Just Published: World Prostate Cancer Therapeutics Market Report
...peciality European Pharma Introduces Plenaxis II-66 Actavis Unveils Bicalutamide Tablets for Prostate Cancer in the European Markets II-66 artemis to Introduce IGRT II-66 Immunomedics Introduces Immunotoxin for Treatment of Prostate and Lung Cancer II-66 Barr Unveils Generic Version o...Artemis Health Hires Richard Rava, Ph.D., as Senior Vice President of Research and Development
... MENLO PARK, Calif., Feb. 9 /PRNewswire/ -- artemis Health Inc., a privately-held company dedicated to...denstein, president and chief executive officer of artemis Health. Dr. Rava brings more than 20 years ...commercial assays and instrumentation. He comes to artemis after 16 years at Affymetrix where he was a scient...Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
...- MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- artemis Health Inc., a privately-held company dedicated to...denstein, president and chief executive officer of artemis Health. "We now have two complementary approaches...enetic analysis. Under the terms of the agreement, artemis received a co-exclusive worldwide license to a sui...Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results
...s, Inc. in September 2007 and an $18.1 million gain on the sale of 80.1% of artemis Pharmaceuticals to Taconic Farms, Inc. in November 2007. The decrease in ne...ed subsidiary of The Dow Chemical Company. -- Sold an 80.1% stake in artemis to Taconic Farms, for $19.8 million. Corporate Development -- Complete...